Evaluation of clinicopathologic correlation of her2neu and activated AKT in metastatic 3+CB11 breast cancer and patient outcomes

Authors

Grace Makari-Judson MD, Baystate HealthFollow
Raavi Gupta MD, Baystate Health
Christopher Otis MD, Baystate HealthFollow

Author Department

Medicine; Pathology

Document Type

Presentations, Research

Publication Date

4-1-2005

Recommended Citation

Ricketts R, Gupta R, Newsome B, Otis C, Makari-Judson G. Evaluation of clinicopathologic correlation of her2neu and activated AKT in metastatic 3+CB11 breast cancer and patient outcomes. American College of Physicians: Internal Medicine. San Francisco, CA. Apr 14-Apr 15, 2005.